Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
SHANGHAI PECHEM
00338
HK Stock MarketDetailed Quotes
CN HEALTH TECH (01069)
- 0.310
- 0.0000.00%
Not Open May 18 16:47 CST
95.72MMarket Cap3.78P/E (TTM)
0.330High0.305Low1.12MVolume0.305Open0.310Prev Close366.64KTurnover0.36%Turnover Ratio3.83P/E (Static)308.77MShares0.37052wk High1.52P/B95.72MFloat Cap0.26752wk Low--Dividend TTM308.77MShs Float115.633Historical High--Dividend LFY8.07%Range %0.267Historical Low0.327Avg Price10000Lot Size--Div Yield TTM--Div Yield LFY
CN HEALTH TECH (01069) Income Statement
All
YOY
| (Q6)Dec 31, 2025 | (FY)Jun 30, 2025 | (Q6)Dec 31, 2024 | (FY)Jun 30, 2024 | (Q6)Dec 31, 2023 | (FY)Jun 30, 2023 | (Q6)Dec 31, 2022 | (FY)Jun 30, 2022 | (Q6)Dec 31, 2021 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 10.55%34.39M | 89.50%90.22M | 63.58%31.11M | -18.92%47.61M | -17.38%19.02M | 769.11%58.72M | 240.75%23.02M | --6.76M | 75.07%6.76M | ---- |
| Operating income | 10.55%34.39M | 89.50%90.22M | 63.58%31.11M | -18.92%47.61M | -17.38%19.02M | 769.11%58.72M | 240.75%23.02M | 6.76M | 75.07%6.76M | |
| Cost of sales | -6.78%-30.26M | -79.40%-82M | -85.66%-28.34M | 3.17%-45.71M | 14.98%-15.26M | -598.74%-47.21M | -165.72%-17.95M | ---6.76M | ---6.76M | ---- |
| Operating expenses | -6.78%-30.26M | -79.40%-82M | -85.66%-28.34M | 3.17%-45.71M | 14.98%-15.26M | -598.74%-47.21M | -165.72%-17.95M | -6.76M | -6.76M | |
| Gross profit | 48.97%4.14M | 332.95%8.21M | -26.10%2.78M | -83.52%1.9M | -25.86%3.76M | 11.51M | 5.07M | 0 | 0 | |
| Selling expenses | -237.16%-499K | 39.34%-862K | 76.24%-148K | -97.36%-1.42M | -13.07%-623K | -1,500.00%-720K | -55,000.00%-551K | 93.43%-45K | 99.43%-1K | ---685K |
| Administrative expenses | 9.82%-8.47M | 26.98%-15.68M | -11.62%-9.39M | -11.84%-21.47M | -56.42%-8.41M | -64.62%-19.2M | -22.50%-5.38M | 62.95%-11.66M | 68.23%-4.39M | ---31.48M |
| Special items of operating profit | -12.40%11.51M | -84.46%34.86M | -93.64%13.14M | 8,057.33%224.25M | 2,309.67%206.75M | -77.82%2.75M | 30.16%8.58M | 102.56%12.4M | 269.37%6.59M | ---484.17M |
| Operating profit | 4.72%6.68M | -86.95%26.53M | -96.83%6.38M | 3,691.61%203.25M | 2,510.07%201.47M | -921.34%-5.66M | 250.86%7.72M | 100.13%689K | 115.68%2.2M | -516.33M |
| Financing cost | -34.48%-1.8M | -8.49%-3.5M | -2,521.57%-1.34M | 72.36%-3.23M | 99.43%-51K | 44.94%-11.68M | -33.58%-8.97M | 37.19%-21.22M | 42.58%-6.71M | ---33.78M |
| Special items of earning before tax | 18,700.00%376K | ---- | -33.33%2K | ---- | -25.00%3K | 5,321.09%7.97M | -87.50%4K | -95.92%147K | -99.15%32K | --3.6M |
| Earning before tax | 4.24%5.26M | -88.49%23.03M | -97.50%5.04M | 2,233.77%200.02M | 16,291.56%201.42M | 54.01%-9.37M | 72.24%-1.24M | 96.27%-20.38M | 79.58%-4.48M | -546.52M |
| Tax | 93.75%-4K | -4,400.00%-315K | -3,100.00%-64K | 99.51%-7K | ---2K | ---1.43M | ---- | ---- | ---- | ---- |
| After-tax profit from continuing operations | 5.50%5.25M | -88.65%22.71M | -97.53%4.98M | 1,951.97%200.01M | 16,291.40%201.42M | 47.01%-10.8M | 72.24%-1.24M | 96.27%-20.38M | 79.67%-4.48M | -546.52M |
| After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 120.85%1.48M | ---977K | ---7.11M |
| Special items of earning after tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 120.85%1.48M | ---977K | ---7.11M |
| Earning after tax | 5.50%5.25M | -88.65%22.71M | -97.53%4.98M | 1,951.97%200.01M | 16,291.40%201.42M | 42.86%-10.8M | 77.21%-1.24M | 96.59%-18.9M | 75.24%-5.46M | -553.63M |
| Shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 96.27%-20.38M | ---4.48M | ---546.52M |
| Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 120.85%1.48M | ---977K | ---7.11M |
| Profit attributable to shareholders | 5.50%5.25M | -88.65%22.71M | -97.53%4.98M | 1,951.97%200.01M | 16,291.40%201.42M | 42.86%-10.8M | 77.21%-1.24M | 96.59%-18.9M | 75.24%-5.46M | -553.63M |
| Basic earnings per share | -16.67%0.0525 | -90.77%0.0275 | -80.38%0.063 | 403.98%0.2979 | 2,941.59%0.3211 | 42.82%-0.098 | -2,160.00%-0.0113 | -241.43%-0.1714 | 75.00%-0.0005 | -0.0502 |
| Diluted earnings per share | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
| Auditor | -- | Zhongzhi Xin (Hong Kong) Certified Public Accountants Limited | -- | Zhongzhi Xin (Hong Kong) Certified Public Accountants Limited | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"